Vimarsana
Biggest News Aggregation in the World

Page 36 - Aptar Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptar Pharma Today - Breaking & Trending Today

Voluntis Announces Partnership with Tilak Healthcare to Help Patients with Cancer Better Manage Ocular Toxicities - Vimarsana News

Voluntis Announces Partnership with Tilak Healthcare to Help Patients with Cancer Better Manage Ocular Toxicities

Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically validated medical mobile apps for chronic diseases. Under this new collaboration, both companies will combine Tilak’s OdySight® Care™ ...

AptarGroup : Voluntis and Tilak Healthcare Partner to Help Cancer Patients Better Manage Ocular Toxicities - Vimarsana News

AptarGroup : Voluntis and Tilak Healthcare Partner to Help Cancer Patients Better Manage Ocular Toxicities

Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically... | February 23, 2022

Aptar Reports Fourth Quarter and Annual 2021 Results - Vimarsana News

Aptar Reports Fourth Quarter and Annual 2021 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Feb 17, 2022--

Source: wsiltv.com
Aptar Pharma MDI Add-on Device Aids in Patient Inhalation Technique, Adherence From: Aptar Pharma - Vimarsana News

Aptar Pharma MDI Add-on Device Aids in Patient Inhalation Technique, Adherence From: Aptar Pharma

Turns a standard metered dose inhaler into a connected device

Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA - Vimarsana News

Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA

Glenmark’s Ryaltris nasal spray, using Aptar Pharma’s VP3 nasal spray system, treats nasal and ocular symptoms.